These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 20025889

  • 1. EGR-1 decoy ODNs inhibit vascular smooth muscle cell proliferation and neointimal hyperplasia of balloon-injured arteries in rat.
    Han W, Liu GN.
    Life Sci; 2010 Feb 13; 86(7-8):234-43. PubMed ID: 20025889
    [Abstract] [Full Text] [Related]

  • 2. Early growth response gene-1 decoy oligonucleotides inhibit vascular smooth muscle cell proliferation and neointimal hyperplasia of autogenous vein graft in rabbits.
    Wang X, Mei Y, Ji Q, Feng J, Cai J, Xie S.
    Interact Cardiovasc Thorac Surg; 2015 Jul 13; 21(1):50-4. PubMed ID: 25820759
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of anastomotic intimal hyperplasia using a chimeric decoy strategy against NFkappaB and E2F in a rabbit model.
    Miyake T, Aoki M, Morishita R.
    Cardiovasc Res; 2008 Sep 01; 79(4):706-14. PubMed ID: 18515844
    [Abstract] [Full Text] [Related]

  • 4. Novel E2F decoy oligodeoxynucleotides inhibit in vitro vascular smooth muscle cell proliferation and in vivo neointimal hyperplasia.
    Ahn JD, Morishita R, Kaneda Y, Kim HS, Chang YC, Lee KU, Park JY, Lee HW, Kim YH, Lee IK.
    Gene Ther; 2002 Dec 01; 9(24):1682-92. PubMed ID: 12457282
    [Abstract] [Full Text] [Related]

  • 5. Molecular strategy using cis-element 'decoy' of E2F binding site inhibits neointimal formation in porcine balloon-injured coronary artery model.
    Nakamura T, Morishita R, Asai T, Tsuboniwa N, Aoki M, Sakonjo H, Yamasaki K, Hashiya N, Kaneda Y, Ogihara T.
    Gene Ther; 2002 Apr 01; 9(8):488-94. PubMed ID: 11948373
    [Abstract] [Full Text] [Related]

  • 6. Transfected synthetic DNA enzyme gene specifically inhibits Egr-1 gene expression and reduces neointimal hyperplasia following balloon injury in rats.
    Liu GN, Teng YX, Yan W.
    Int J Cardiol; 2008 Sep 16; 129(1):118-24. PubMed ID: 18242730
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of neointimal hyperplasia after balloon injury by cis-element 'decoy' of early growth response gene-1 in hypercholesterolemic rabbits.
    Ohtani K, Egashira K, Usui M, Ishibashi M, Hiasa KI, Zhao Q, Aoki M, Kaneda Y, Morishita R, Takeshita A.
    Gene Ther; 2004 Jan 16; 11(2):126-32. PubMed ID: 14712296
    [Abstract] [Full Text] [Related]

  • 8. Local delivery of E2F decoy oligodeoxynucleotides using ultrasound with microbubble agent (Optison) inhibits intimal hyperplasia after balloon injury in rat carotid artery model.
    Hashiya N, Aoki M, Tachibana K, Taniyama Y, Yamasaki K, Hiraoka K, Makino H, Yasufumi K, Ogihara T, Morishita R.
    Biochem Biophys Res Commun; 2004 Apr 30; 317(2):508-14. PubMed ID: 15063786
    [Abstract] [Full Text] [Related]

  • 9. [Expression of early growth response gene-1 and its correlative genes in autogenous vein graft and significance thereof: an experiment with rats].
    Liu CW, Hu XH, Yang J, Zhang Q, Zhang XS, Duan ZQ.
    Zhonghua Yi Xue Za Zhi; 2005 Dec 21; 85(48):3414-8. PubMed ID: 16409863
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of intimal hyperplasia after balloon injury in rat carotid artery model using cis-element 'decoy' of nuclear factor-kappaB binding site as a novel molecular strategy.
    Yoshimura S, Morishita R, Hayashi K, Yamamoto K, Nakagami H, Kaneda Y, Sakai N, Ogihara T.
    Gene Ther; 2001 Nov 21; 8(21):1635-42. PubMed ID: 11895002
    [Abstract] [Full Text] [Related]

  • 11. The role of ex-vivo gene therapy of vein grafts with Egr-1 decoy in the suppression of intimal hyperplasia.
    Peroulis M, Kakisis J, Kapelouzou A, Giagini A, Giaglis S, Mantziaras G, Kostomitsopoulos N, Karayannacos P, Macheras A.
    Eur J Vasc Endovasc Surg; 2010 Aug 21; 40(2):216-23. PubMed ID: 20537569
    [Abstract] [Full Text] [Related]

  • 12. Long-term stabilization of vein graft wall architecture and prolonged resistance to experimental atherosclerosis after E2F decoy oligonucleotide gene therapy.
    Ehsan A, Mann MJ, Dell'Acqua G, Dzau VJ.
    J Thorac Cardiovasc Surg; 2001 Apr 21; 121(4):714-22. PubMed ID: 11279413
    [Abstract] [Full Text] [Related]

  • 13. Suppression of growth factor expression and human vascular smooth muscle cell growth by small interfering RNA targeting EGR-1.
    Fahmy RG, Khachigian LM.
    J Cell Biochem; 2007 Apr 15; 100(6):1526-35. PubMed ID: 17171647
    [Abstract] [Full Text] [Related]

  • 14. Tanshinone IIA inhibits smooth muscle proliferation and intimal hyperplasia in the rat carotid balloon-injured model through inhibition of MAPK signaling pathway.
    Li X, Du JR, Yu Y, Bai B, Zheng XY.
    J Ethnopharmacol; 2010 May 27; 129(2):273-9. PubMed ID: 20363310
    [Abstract] [Full Text] [Related]

  • 15. [Effect of RNA interference targeting mammalian target of rapamycin on the proliferation of vascular smooth muscle cell and the intimal hyperplasia].
    Hu XH, Zhang Q, Yang J, Liu CW, Zhang ZS, Yang DH.
    Zhonghua Yi Xue Za Zhi; 2007 Jan 02; 87(1):58-62. PubMed ID: 17403315
    [Abstract] [Full Text] [Related]

  • 16. RNA interference targeting ORC1 gene suppresses the proliferation of vascular smooth muscle cells in rats.
    Shu MQ, Qin YL, Jiang MH.
    Exp Mol Pathol; 2008 Jun 02; 84(3):206-12. PubMed ID: 18499104
    [Abstract] [Full Text] [Related]

  • 17. Tissue-specific expression of an anti-proliferative hybrid transgene from the human smooth muscle alpha-actin promoter suppresses smooth muscle cell proliferation and neointima formation.
    Wills KN, Mano T, Avanzini JB, Nguyen T, Antelman D, Gregory RJ, Smith RC, Walsh K.
    Gene Ther; 2001 Dec 02; 8(24):1847-54. PubMed ID: 11821938
    [Abstract] [Full Text] [Related]

  • 18. c-Myb-dependent inositol 1,4,5-trisphosphate receptor type-1 expression in vascular smooth muscle cells.
    Afroze T, Sadi AM, Momen MA, Gu S, Heximer S, Husain M.
    Arterioscler Thromb Vasc Biol; 2007 Jun 02; 27(6):1305-11. PubMed ID: 17363689
    [Abstract] [Full Text] [Related]

  • 19. Altered S-phase kinase-associated protein-2 levels are a major mediator of cyclic nucleotide-induced inhibition of vascular smooth muscle cell proliferation.
    Wu YJ, Bond M, Sala-Newby GB, Newby AC.
    Circ Res; 2006 May 12; 98(9):1141-50. PubMed ID: 16574903
    [Abstract] [Full Text] [Related]

  • 20. Dominant negative insulin-like growth factor-1 receptor inhibits neointimal formation through suppression of vascular smooth muscle cell migration and proliferation, and induction of apoptosis.
    Lim HJ, Park HY, Ko YG, Lee SH, Cho SY, Lee EJ, Jameson JL, Jang Y.
    Biochem Biophys Res Commun; 2004 Dec 17; 325(3):1106-14. PubMed ID: 15541402
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.